Leverage the power of our FDA-Cleared Immunoturbidimetric (IT) Assay for fecal calprotectin designed to integrate seamlessly with your existing clinical chemistry analyzer. Experience a method that is not only time and cost-efficient but also a viable alternative to conventional and send-out methodologies.
See for yourself why labs are switching to ALPCO’s new FDA-cleared Calprotectin Immunoturbidimetric Assay.
One free kit per laboratory. Void where prohibited.
Automation: Streamlined Process
Enhance operational efficiency by minimizing labor and maximizing output, ensuring consistency and precision in your results from extraction to results.
GET YOUR TIME BACK
Upgrading to ALPCO’s Immunoturbidimetric solution for calprotectin testing offers a 40%-65% reduction in time to first result compared to leading Flash Chemiluminescence automated systems.
MAXIMIZE THROUGHPUT
Increase throughput by more than 57% when comparing tests per hour from a leading CLIA system to ALPCO’s Immunoturbidimetric assay running on a clinical chemistry analyzer.
ACCURACY
ALPCO’s Calprotectin IT Assay combines the clinical sensitivity and specificity clinicians expect with the efficiency and repeatability today’s laboratories require.
Clinical Accuracy: Results You Can Trust
Achieve the clinical specificity your patients deserve without compromising clinical sensitivity. The assay boasts a clinical sensitivity of 91% and a clinical specificity of 93%, ensuring low false negatives and false positives, respectively.
Cost-Effective: Maximize Savings
Ensure savings on both labor and kit costs without compromising quality. The cost per test for ALPCO’s Calprotectin IT Assay is typically far less than the send out price. Some customers can realize up to an 87% cost savings.
COST SAVINGS
Realize a savings of up to 87% on the cost per test when comparing the average send-out cost to ALPCO’s in-house cost per test.
Simplicity, Efficiency, and Cost Effectiveness, All While Elevating Confidence in Your Results.
Calprotectin Immunoturbidimetric Assay
The Calprotectin Immunoturbidimetric Assay is an in vitro diagnostic particle-enhanced immunoassay for the quantitative measurement of fecal calprotectin, a neutrophilic protein that is a marker of intestinal mucosal inflammation, in human stool. The assay is intended for use as an aid in the diagnosis of inflammatory bowel disease (IBD), specifically Crohn’s disease (CD) and ulcerative colitis (UC), and as an aid in the differentiation of IBD from irritable bowel syndrome (IBS) in conjunction with other clinical and laboratory findings.
